We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The effect of preoperative phenazopyridine on short-term urinary retention following urogynecologic surgery.
- Authors
McSwain, Sallie; Woll, Abbigail; Edenfield, Autumn; Kesty, Kendra; Brong, Kyle; Swift, Steven
- Abstract
Introduction and hypothesis: Previous studies have found that administration of phenazopyridine decreased short-term urinary retention following surgery but other more recent trials have shown mixed results. This study sought to investigate the potential benefit of preoperative administration of oral phenazopyridine in relation to the prevention of short-term urinary retention following urogynecologic surgery. Methods: This is a retrospective cohort study of a convenience sample of women undergoing urogynecologic surgery from June 2016 to March 2019. Following surgery, subjects underwent a standardized retrograde voiding trial. The data had previously been gathered from a prior prospective trial at our institution (Kesty et al. Int Urogynecol J 31(9):1899–1905, 11). Chart review was performed to determine whether patients that received 200 mg of preoperative oral phenazopyridine to better visualize ureteral efflux during cystourethroscopy were more or less likely to pass their postoperative voiding trial. Bivariate statistical analysis was performed as well as a multivariate logistic regression model. Results: A total of 165 subjects were included in the final analysis; 100 who did not receive preoperative phenazopyridine and 65 who did receive phenazopyridine. There was no statistical difference between voiding trial pass rates following urogynecologic surgery between those who did not receive preoperative phenazopyridine compared to those who did [77% (77/100) and 82% (53/65), respectively, p = 0.37)]. The multivariate logistic regression model demonstrated no difference in postoperative voiding trial pass rates among those who received preoperative phenazopyridine compared to those who did not (OR 1.7, 95% CI: 0.53, 5.8). Conclusions: Preoperative administration of oral phenazopyridine does not decrease short-term urinary retention following urogynecologic surgery.
- Subjects
UROGYNECOLOGIC surgery; RETENTION of urine; GYNECOLOGIC surgery; BIVARIATE analysis; LOGISTIC regression analysis; REGRESSION analysis
- Publication
International Urogynecology Journal, 2022, Vol 33, Issue 3, p711
- ISSN
0937-3462
- Publication type
Academic Journal
- DOI
10.1007/s00192-021-04699-w